254 related articles for article (PubMed ID: 6327848)
1. Molecular dissection of the humoral immune response to individual varicella-zoster viral proteins during chickenpox, quiescence, reinfection, and reactivation.
Weigle KA; Grose C
J Infect Dis; 1984 May; 149(5):741-9. PubMed ID: 6327848
[TBL] [Abstract][Full Text] [Related]
2. IgM and IgG responses to varicella-zoster virus p32/p36 complex after chickenpox and zoster, congenital and subclinical infections, and vaccination.
Harper DR; Grose C
J Infect Dis; 1989 Mar; 159(3):444-51. PubMed ID: 2536788
[TBL] [Abstract][Full Text] [Related]
3. Antibody to early antigens of varicella-zoster virus during varicella and zoster.
Gerna G; Cereda PM; Cattaneo E; Achilli G; Gerna MT
J Infect Dis; 1979 Jul; 140(1):33-41. PubMed ID: 88490
[TBL] [Abstract][Full Text] [Related]
4. Investigation of varicella-zoster virus-infected cell proteins that elicit antibody production during primary varicella using the immune transfer method.
Palumbo PE; Arvin AM; Koropchak CM; Wittek AE
J Gen Virol; 1984 Dec; 65 ( Pt 12)():2141-7. PubMed ID: 6096492
[TBL] [Abstract][Full Text] [Related]
5. Cellular and humoral immunity to varicella zoster virus glycoproteins in immune and susceptible human subjects.
Giller RH; Winistorfer S; Grose C
J Infect Dis; 1989 Dec; 160(6):919-28. PubMed ID: 2555419
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to the three major glycoproteins of varicella-zoster virus: search for the relevant host immune response.
Brunell PA; Novelli VM; Keller PM; Ellis RW
J Infect Dis; 1987 Sep; 156(3):430-5. PubMed ID: 3039010
[TBL] [Abstract][Full Text] [Related]
7. Neutralizing antibody responses induced by varicella-zoster virus gE and gB glycoproteins following infection, reactivation or immunization.
Haumont M; Jurdan M; Kangro H; Jacquet A; Massaer M; Deleersnyder V; Garcia L; Bosseloir A; Bruck C; Bollen A; Jacobs P
J Med Virol; 1997 Sep; 53(1):63-8. PubMed ID: 9298734
[TBL] [Abstract][Full Text] [Related]
8. Reactivity of varicella-zoster virus subunit antigens in enzyme-linked immunosorbent assay to sera from varicella, zoster, and herpes simplex virus infections.
Takayama M
Med Microbiol Immunol; 1994 Feb; 183(1):1-11. PubMed ID: 8202026
[TBL] [Abstract][Full Text] [Related]
9. Antibodies to varicella-zoster virus glycoproteins I, II, and III in leukemic and healthy children.
LaRussa PS; Gershon AA; Steinberg SP; Chartrand SA
J Infect Dis; 1990 Sep; 162(3):627-33. PubMed ID: 2167335
[TBL] [Abstract][Full Text] [Related]
10. Congenital varicella-zoster virus infection and the failure to establish virus-specific cell-mediated immunity.
Grose C
Mol Biol Med; 1989 Oct; 6(5):453-62. PubMed ID: 2560525
[TBL] [Abstract][Full Text] [Related]
11. Common expression of varicella-zoster viral glycoprotein antigens in vitro and in chickenpox and zoster vesicles.
Weigle KA; Grose C
J Infect Dis; 1983 Oct; 148(4):630-8. PubMed ID: 6313814
[TBL] [Abstract][Full Text] [Related]
12. The optimization and validation of the glycoprotein ELISA assay for quantitative varicella-zoster virus (VZV) antibody detection.
Hammond O; Wang Y; Green T; Antonello J; Kuhn R; Motley C; Stump P; Rich B; Chirmule N; Marchese RD
J Med Virol; 2006 Dec; 78(12):1679-87. PubMed ID: 17063506
[TBL] [Abstract][Full Text] [Related]
13. Serum immunoglobulin A antibody to varicella-zoster virus in subjects with primary varicella and herpes zoster infections and in immune subjects.
Wittek AE; Arvin AM; Koropchak CM
J Clin Microbiol; 1983 Nov; 18(5):1146-9. PubMed ID: 6315766
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulins M and G to varicella-zoster virus measured by solid-phase radioimmunoassay: antibody responses to varicella and herpes zoster infections.
Arvin AM; Koropchak CM
J Clin Microbiol; 1980 Sep; 12(3):367-74. PubMed ID: 6260833
[TBL] [Abstract][Full Text] [Related]
15. Antibody responses to early antigens of varicella-zoster virus (VZV) during varicella and zoster.
Namazue J; Kato T; Yamanishi K; Takahashi M; Asano Y; Muraki R
Biken J; 1986 Dec; 29(3-4):91-7. PubMed ID: 3039973
[TBL] [Abstract][Full Text] [Related]
16. Detection of varicella-zoster virus-specific IgA antibodies in varicella and zoster patients and in healthy adults of various ages by solid-phase radioimmunoassay.
Levy E; Mosovitz B; Friedman M; Sarov I
Intervirology; 1983; 20(2-3):123-8. PubMed ID: 6313543
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of a recombinant varicella-zoster virus gE-IE63 fusion protein, a putative vaccine candidate against primary infection and zoster reactivation.
Jacquet A; Haumont M; Massaer M; Garcia L; Mazzu P; Daminet V; Grégoire D; Jacobs P; Bollen A
Vaccine; 2002 Feb; 20(11-12):1593-602. PubMed ID: 11858867
[TBL] [Abstract][Full Text] [Related]
18. Serological detection of varicella-zoster virus-specific immunoglobulin G by an enzyme-linked immunosorbent assay using glycoprotein antigen.
Sauerbrei A; Wutzler P
J Clin Microbiol; 2006 Sep; 44(9):3094-7. PubMed ID: 16954232
[TBL] [Abstract][Full Text] [Related]
19. Serological detection of specific IgG to varicella-zoster virus by novel ELISA based on viral glycoprotein antigen.
Sauerbrei A; Wutzler P
Clin Lab; 2009; 55(1-2):1-7. PubMed ID: 19350844
[TBL] [Abstract][Full Text] [Related]
20. Clinical reinfection with varicella-zoster virus.
Gershon AA; Steinberg SP; Gelb L
J Infect Dis; 1984 Feb; 149(2):137-42. PubMed ID: 6321605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
